Cancer surgery during the COVID-19 pandemic: The experience of a comprehensive cancer center performing preoperative screening by RT-PCR and chest CT scan.


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 24 11 2020
revised: 30 11 2020
accepted: 30 11 2020
pubmed: 2 2 2021
medline: 4 3 2021
entrez: 1 2 2021
Statut: ppublish

Résumé

During the worldwide pandemic of coronavirus disease 2019 (COVID-19), oncological procedures considered to be urgent could not be delayed, and a specific procedure was required to continue surgical activity. The objective was to assess the efficacy of our preoperative screening algorithm. This observational retrospective study was performed between the 25th of March and the 12th of May 2020 in a comprehensive cancer center in France. Patients undergoing elective oncologic surgery were tested by preoperative nasopharyngeal reverse-transcription polymerase chain reaction (RT-PCR) that could be associated with a chest computerized tomography (CT) scan. Of the 510 screening tests (in 477 patients), only 5% (15/477) were positive for COVID-19 in 24 patients (18 RT-PCR+ and 7 CT scan+/RT-PCR-). Four patients were ultimately false positives based on the CT scan. In total, only 4.2% (20/477) of the patients were COVID-19+. The positivity rate decreased with time after the containment measures were implemented (from 7.4% to 0.8%). In the COVID-19+ group, 20% of the patients had postoperative pulmonary complications, whereas this was the case for 5% of the patients in the COVID-19 group. Maintaining secure surgical activity is achievable and paramount in oncology care, even during the COVID-19 pandemic, with appropriate screening based on preoperative RT-PCR.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
During the worldwide pandemic of coronavirus disease 2019 (COVID-19), oncological procedures considered to be urgent could not be delayed, and a specific procedure was required to continue surgical activity. The objective was to assess the efficacy of our preoperative screening algorithm.
METHODS METHODS
This observational retrospective study was performed between the 25th of March and the 12th of May 2020 in a comprehensive cancer center in France. Patients undergoing elective oncologic surgery were tested by preoperative nasopharyngeal reverse-transcription polymerase chain reaction (RT-PCR) that could be associated with a chest computerized tomography (CT) scan.
RESULTS RESULTS
Of the 510 screening tests (in 477 patients), only 5% (15/477) were positive for COVID-19 in 24 patients (18 RT-PCR+ and 7 CT scan+/RT-PCR-). Four patients were ultimately false positives based on the CT scan. In total, only 4.2% (20/477) of the patients were COVID-19+. The positivity rate decreased with time after the containment measures were implemented (from 7.4% to 0.8%). In the COVID-19+ group, 20% of the patients had postoperative pulmonary complications, whereas this was the case for 5% of the patients in the COVID-19 group.
CONCLUSIONS CONCLUSIONS
Maintaining secure surgical activity is achievable and paramount in oncology care, even during the COVID-19 pandemic, with appropriate screening based on preoperative RT-PCR.

Identifiants

pubmed: 33524172
doi: 10.1002/jso.26335
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

815-822

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Yeoh CB, Lee KJ, Rieth EF, et al. COVID in the cancer patient. Anesth Analg. 2020;131:16-23. https://doi.org/10.1213/ANE.0000000000004884
Ambulatory Surgery Center Association (ASCA) Ambulatory Surgery Center Association Foundation: COVID-19: Guidance for ASCs on Necessary Surgeries. https://www.ascassociation.org/asca/resourcecenter/latestnewsresourcecenter/covid-19/covid-19-guidance. Accessed March 31, 2020.
American College of Surgeons: COVID-19: Guidance for Triage of Non-Emergent Surgical Procedures. https://www.facs.org/covid-19/clinical-guidance/triage. Accessed March 31, 2020.
American College of Surgeons: COVID-19: Elective Case Triage Guideline for Surgical Care. https://www.facs.org/covid-19/clinical-guidance/elective-case. Accessed March 24, 2020.
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335-337.
COVID Surg Collaborative: Mortality and Pulmonary Complications in Patients Undergoing Surgery with Perioperative SARS-CoV-2 Infection: an International Cohort Study. Lancet. 2020;396:27-38. https://doi.org/10.1016/S0140-6736(20)31182-X
Kokkinakis I, Selby K, Favrat B, et al. Performance du frottis nasopharyngé-PCR pour le diagnostic du Covid-19. Recommandations pratiques sur la base des premières données scientifiques. Rev Med Suisse. 2020;16:699-670.
Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;296:E115-E117.
Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296:E32-E40.
Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843-1844.
Kim H, Hong H, Yoon SH. Diagnostic performance of CT and reverse transcriptase-polymerase chain reaction for coronavirus disease 19: a meta-analysis. Radiology. 2020;296:E145-E155.
Li Y, Yao L, Li J, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol. 2020;92:903-908. https://doi.org/10.1002/jmv.25786
Liu R, Han H, Liu F, et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta. 2020;505:172-175. https://doi.org/10.1016/j.cca.2020.03.009
Dépistage pré-opératoire du COVID-19: l′avis de la SPILF (Société de Pathologie Infectieuse de Langue Française). https://www.infectiologie.com/fr/actualites/depistage-pre-operatoire-du-covid-19-l-avis-de-la-spilf-n.html. Accessed June 14, 2020.
Santé Publique France. COVID-19: point épidémiologique hebdomadaire du 4 juin 2020, situation au 2 juin 2020. https://www.santepubliquefrance.fr/recherche/#search=COVID%2019%20%20%20point%20epidemiologique&publications=donnees&regions=National&sort=date. Accessed June 11, 2020.
Intercollegiate Guidelines for pre-operative COVID-19 testing for elective Cancer surgery update. https://www.rcsed.ac.uk/news-public-affairs/news/2020/may/intercollegiate-guidelines-for-pre-operative-covid-19-testing-for-elective-cancer-surgery-update. Accessed May 13, 2020.
Centers for Disease Control and Prevention. Overview of Influenza Surveillance in the United States. https://www.cdc.gov/flu/pdf/weekly/overview-update.pdf. Accessed May 13, 2020.
ASA and APSF Joint Statement on perioperative Testing for the COVID-19 Virus. https://www.apsf.org/news-updates/asa-and-apsf-joint-statement-on-perioperative-testing-for-the-covid-19-virus. Accessed April 29, 2020.
Ohana M, Revel MP, Lederlin M, et al. Imagerie thoracique au déconfinement-positionnement de la SIT. https://ebulletin.radiologie.fr/actualites-covid-19/imagerie-thoracique-au-deconfinement-positionnement-sit-07052020. Accessed May 7, 2020.
Schultz P, Morvan JB, Fakhry N, et al. French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137:167-169.
Fakhry N, Schultz P, Morinière S, et al. French consensus on management of head and neck cancer surgery during COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137:159-160.
Huybens EM, Bus MPA, Massaad RA, et al. What is the preferred screening tool for COVID-19 in asymptomatic patients undergoing a surgical or diagnostic procedure? World J Surg. 2020;44:3199-3206.
Tahamtan A, Ardebili A. Ral-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn. 2020;20:453-454. https://doi.org/10.1080/14737159.2020.1757437
Peeling RW, Wedderburn CJ, Garcia PJ, et al. Serology testing in the COVID-19 pandemic response. Lancet Infect Dis. 2020;20:e245-e249.

Auteurs

Joanne Guerlain (J)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Fabienne Haroun (F)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Alexandra Voicu (A)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Charles Honoré (C)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Franck Griscelli (F)

Department of Laboratory Medicine and Pathology, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Stéphane Temam (S)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Nadia Benmoussa (N)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Philippe Gorphe (P)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Thierry de Baere (T)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Samy Ammari (S)

Department of Medical Imaging, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Gabriel Garcia (G)

Department of Medical Imaging, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Corinne Balleyguier (C)

Department of Medical Imaging, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Françoise Rimareix (F)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Sébastien Gouy (S)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Philippe Sitbon (P)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Bertrand Gachot (B)

Infectious Diseases Unit, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Ingrid Breuskin (I)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Stéphanie Suria (S)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Antoine Moya-Plana (A)

Surgical and Interventional Department, Paris-Saclay University, Gustave Roussy, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH